Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform
Torben Gjetting, Monika Gad, Camilla Fröhlich, et al.
mAbs (2019) Vol. 11, Iss. 4, pp. 666-680
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
Katrin Pansy, Barbara Uhl, Jelena Krstić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13311-13311
Open Access | Times Cited: 82
IgY antibodies: The promising potential to overcome antibiotic resistance
Sherif A. El‐Kafrawy, Aymn T. Abbas, Christopher Oelkrug, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
The importance of binding kinetics and drug–target residence time in pharmacology
Kevin E. Knockenhauer, Robert A. Copeland
British Journal of Pharmacology (2023) Vol. 181, Iss. 21, pp. 4103-4116
Closed Access | Times Cited: 27
CD4+ and CD8a+ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models
Lotte K. Kristensen, Camilla Fröhlich, Camilla L. Christensen, et al.
Theranostics (2019) Vol. 9, Iss. 26, pp. 8221-8238
Open Access | Times Cited: 70
Trends in industrialization and commercialization of IgY technology
Saeed Yakhkeshi, Rao Wu, Brindha Chelliappan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Egg Yolk Antibody for Passive Immunization: Status, Challenges, and Prospects
Huiwen Wang, Qixin Zhong, Jun Lin
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 13, pp. 5053-5061
Closed Access | Times Cited: 15
The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
Mazdak Ganjalikhani‐Hakemi, Morteza Jafarinia, Mahdieh Azizi, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
Assessing the binding properties of the anti-PD-1 antibody landscape using label-free biosensors
Michael E. Brown, Daniel Bedinger, Asparouh Lilov, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0229206-e0229206
Open Access | Times Cited: 30
Landscape of Non-canonical Cysteines in Human VH Repertoire Revealed by Immunogenetic Analysis
Ponraj Prabakaran, Partha S. Chowdhury
Cell Reports (2020) Vol. 31, Iss. 13, pp. 107831-107831
Open Access | Times Cited: 30
Ultra-stable Biomembrane Force Probe for Accurately Determining Slow Dissociation Kinetics of PD-1 Blockade Antibodies on Single Living Cells
Chenyi An, Wei Hu, Jie Gao, et al.
Nano Letters (2020) Vol. 20, Iss. 7, pp. 5133-5140
Closed Access | Times Cited: 27
Isolation of Common Light Chain Antibodies from Immunized Chickens Using Yeast Biopanning and Fluorescence‐Activated Cell Sorting
Jan P. Bogen, Juliana Storka, Desislava Yanakieva, et al.
Biotechnology Journal (2020) Vol. 16, Iss. 3
Open Access | Times Cited: 19
Humanization of Chicken‐Derived scFv Using Yeast Surface Display and NGS Data Mining
Adrian Elter, Jan P. Bogen, Steffen C. Hinz, et al.
Biotechnology Journal (2020) Vol. 16, Iss. 3
Open Access | Times Cited: 16
Golden Gate assembly with a bi-directional promoter (GBid): A simple, scalable method for phage display Fab library creation
Karuppiah Chockalingam, Zeyu Peng, Christine N. Vuong, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Highly Potent Immunotoxins Targeting the Membrane-distal N-lobe of GPC3 for Immunotherapy of Hepatocellular Carcinoma
Jingwen Li, Lanxin Xiang, Qian Wang, et al.
Journal of Cancer (2022) Vol. 13, Iss. 4, pp. 1370-1384
Open Access | Times Cited: 9
Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity
Adrian Elter, Desislava Yanakieva, David Fiebig, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 11
Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
Soma S. R. Banik, Natasha Kushnir, Benjamin J. Doranz, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Humanization of Chicken-Derived Antibodies by Yeast Surface Display
Jan P. Bogen, Adrian Elter, Julius Grzeschik, et al.
Methods in molecular biology (2022), pp. 335-360
Closed Access | Times Cited: 7
Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies
Jordi Pfeifer Serrahima, Katrin Schoenfeld, Ines Kühnel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
Vishwanatha R. A. P. Reddy, William Mwangi, Yashar Sadigh, et al.
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 10
Expression of human lambda expands the repertoire of OmniChickens
Kathryn H. Ching, Kimberley Berg, Jacqueline Morales, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0228164-e0228164
Open Access | Times Cited: 6
Animal immunization merges with innovative technologies: A new paradigm shift in antibody discovery
Ponraj Prabakaran, Sambasiva P. Rao, Maria Wendt
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
Yizhou Zhang, Ruicheng Wei, Ge Song, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access
Chicken‐derived CD20 antibodies with potent B‐cell depletion activity
Karuppiah Chockalingam, Anil Kumar, Jianxun Song, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 560-571
Open Access | Times Cited: 2
Induction and Potential Reversal of a T Cell Exhaustion-Like State: In Vitro Potency Assay for Functional Screening of Immune Checkpoint Drug Candidates
Eden Kleiman, Wushouer Ouerkaxi, Marc Delcommenne, et al.
Methods in pharmacology and toxicology (2020), pp. 73-88
Closed Access | Times Cited: 1
Vom Huhn abgeleitete Antikörper für Diagnostik und Immuntherapie
Adrian Elter, Jan P. Bogen, Jan Habermann, et al.
BIOspektrum (2021) Vol. 27, Iss. 5, pp. 500-504
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top